Showing results (2391-2400 of 5,049) with videos related to
Sort By:
Pageof 505
Headache|January 29, 2024
Effect of prednisolone for the treatment of medication-overuse headache: A 3-month result from a multicenter REgistry for Load and management of mEdicAtion overuSE headache (RELEASE) studyMi Ji Lee, Hong-Kyun Park, Sun-Young Oh, et al.Headache|January 29, 2024
Daith piercing: Revisited from the perspective of auricular acupuncture systems. A narrative reviewSaroj K Pradhan, Andreas R Gantenbein, Yiming Li, et al.Headache|January 30, 2024
Regulation of headache response and transcriptomic network by the trigeminal ganglion clockChorong Han, Ji Ye Lim, Nobuya Koike, et al.Headache|September 9, 2024
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraineJessica Ailani, Pranav Gandhi, Anjana Lalla, et al.Headache|September 9, 2024
Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort studyJasjit K Multani, Robert Urman, Andrew S Park, et al.Headache|September 9, 2024
Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open-label, clinical trialOmar A Almohammed, Sary Alsanea, Nouf Albishi, et al.Headache|August 28, 2024
Cognitive symptoms in veterans with migraine or traumatic brain injury: A Million Veteran Program studyMatthew S Herbert, Victoria C Merritt, Niloofar Afari, et al.Headache|August 28, 2024
The combined impact of migraine and gestational diabetes on long-term risk of premature myocardial infarction and stroke: A population-based cohort studyCecilia H Fuglsang, Lars Pedersen, Morten Schmidt, et al.Headache|August 28, 2024
Healthcare resource use and costs associated with the misdiagnosis of migraineJae Rok Kim, Tae Jin Park, Maria Agapova, et al.Headache|September 2, 2024
Effects of fremanezumab on migraine-associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double-blind, placebo-controlled trialMuneto Tatsumoto, Miki Ishida, Katsuhiro Iba, et al.Pageof 505